The invention provides methods of monitoring amyotrophic lateral sclerosis (ALS) disease development or progression and monitoring an ALS therapy in an individual by determining the presence or absence of Herv-K/HML-2 expression in a biological sample from the individual. The invention is also directed...http://www.google.com.au/patents/US20060160087?utm_source=gb-gplus-sharePatent US20060160087 - Monitoring and treatment of amyotrophic lateral sclerosis
